CMAJ • February 27, 2007; 176 (5). doi:10.1503/cmaj.1060174.
© 2007 Canadian Medical Association or its licensors
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marasinghe, J. P.
Right arrow Articles by Amarasinghe, A.A.W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marasinghe, J. P.
Right arrow Articles by Amarasinghe, A.A.W.
Related Collections
Right arrow Drugs: immunological products and vaccines
Right arrow Sexually transmitted infections

Letters

Controlling cervical cancer

Jeevan P. Marasinghe* and A.A.W. Amarasinghe{dagger}

Registrar in Obstetrics and Gynecology, Teaching Hospital, Peradeniya, Sri Lanka;* Psychiatrist, McDonough, Ga.{dagger}

There has been striking progress in research into cervical cancer prevention. According to a CMAJ news article by Alicia Priest, a vaccine against human papillomavirus types 6 and 18 is about to be introduced in Canada.1 As Priest notes in the article, fears have been expressed that administration of the vaccine to young girls might increase sexual promiscuity.2 Moreover, there are concerns about how comfortable young women, parents and health care providers will be about discussing the vaccine.3

Despite the availability of the vaccine, policy-makers should not abandon more cost-effective methods of controlling the burden of cervical cancer,4 such as regular Papanicolaou screening and health education regarding the risk factors for human papillomavirus infection and the clinical problems and long-term complications associated with the infection. These methods have yet to be effectively implemented in some countries.5

After the vaccine is introduced, it will be a few years before a reduction in cervical cancer incidence is detectable. In the meantime, it is important to maintain the existing screening programs and to study the acceptability of the vaccine and the feasibility of the programs to administer it.

REFERENCES

  1. Priest A. Cervical cancer vaccine may come soon to Canada. CMAJ 2006;175(3):235.[Free Full Text]
  2. Monk BJ, Wiley DJ. Will widespread human papillomavirus prophylactic vaccination change sexual practices of adolescent and young adult women in America? Obstet Gynecol 2006;108(2):420-4.[CrossRef][Medline]
  3. Zimet GD. Understanding and overcoming barriers to human papillomavirus vaccine acceptance. Curr Opin Obstet Gynecol 2006;18(1 Suppl):23S-28S.
  4. Mandelblatt JS, Lawrence WF, Gaffikin L, et al. Costs and benefits of different strategies to screen for cervical cancer in less developed countries. J Natl Cancer Inst 2002;94(19):1469-83.[Abstract/Free Full Text]
  5. Monsoneqo J. Cervical cancer prevention: the impact of HPV vaccination. Gynecol Obstet Fertil 2006;34(3):189-201.[CrossRef][Medline]




This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marasinghe, J. P.
Right arrow Articles by Amarasinghe, A.A.W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marasinghe, J. P.
Right arrow Articles by Amarasinghe, A.A.W.
Related Collections
Right arrow Drugs: immunological products and vaccines
Right arrow Sexually transmitted infections